Mediastinoscopy

Worldwide Endoscopy Industry to 2026 - by Product, Application, End-use and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022

In 2021, the flexible endoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period.

Key Points: 
  • In 2021, the flexible endoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period.
  • Disposable endoscopy segment projected to grow at the fastest CAGR during the forecast period.
  • Based on application, the market is categorized into laparoscopy, gastrointestinal (GI) endoscopy, obstetrics/gynaecology endoscopy, urology endoscopy (cystoscopy), arthroscopy, bronchoscopy, otoscopy, mediastinoscopy, laryngoscopy, and others.
  • The gastrointestinal (GI) endoscopy segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period.

Olympus Supports CMS Coverage Decision for Lung Cancer Screening

Retrieved on: 
Tuesday, May 24, 2022

CENTER VALLEY, Pa., May 24, 2022 /PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services (CMS) decision to expand lung cancer screening eligibility for those covered by Medicare.

Key Points: 
  • CENTER VALLEY, Pa., May 24, 2022 /PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services (CMS) decision to expand lung cancer screening eligibility for those covered by Medicare.
  • Earlier screening and detection may save the lives of those diagnosed with non-small cell lung cancer," said Paul Skodny, Executive Director of Global Health Economics and Market Access at Olympus Corporation of the Americas.
  • "Still, there is much work to be done to align CMS coverage through Medicare and Medicaid with lung cancer screening guidance so that the barriers to screening are eliminated."
  • Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.